IUI Success Rate: Real Numbers by Age, Cycle and When to Consider IVF

Written by Dr. Neha Yadav, Associate Consultant, Renew Healthcare

When couples begin exploring fertility treatment, one of the first questions they usually ask is: "What is the success rate of IUI?"

It sounds like a straightforward question. However, the answer is not always as simple as a percentage.

You may hear one clinic mention a 15% success rate, another quote 40%, and an online article promise an 80% chance of pregnancy within six cycles. These numbers can look confusing, especially when you are already navigating the emotional and financial challenges of infertility.

The important thing to understand is that these figures may be measuring entirely different outcomes.

Some report pregnancy per treatment cycle, while others calculate cumulative pregnancy rates over several cycles. Some count a positive pregnancy test, others count pregnancies confirmed by ultrasound, and some report actual live births.

In this article, I will explain what published research tells us about IUI success rates, how age and sperm count influence the outcomes, how many cycles couples may consider, and when moving to IVF becomes a reasonable next step.

What Is the Real Success Rate of IUI?

Intrauterine insemination (IUI) is a fertility treatment in which specially prepared sperm is placed directly inside the uterus around the time of ovulation.

The procedure helps bring sperm closer to the egg, reducing the distance sperm needs to travel. It is commonly considered in selected cases of unexplained infertility, certain ovulation disorders, mild male-factor infertility and donor sperm treatment.

However, there is no single success rate that applies to every couple.

According to the European IVF-Monitoring Consortium's 2020 registry data:

• IUI using a partner's sperm resulted in an 8.8% delivery rate per cycle.

• IUI using donor sperm resulted in a 12.5% delivery rate per cycle.

These figures represent deliveries per treatment cycle, not simply positive pregnancy tests.

The registry included 112,663 partner-sperm IUI cycles across reporting institutions.

Other research has reported different percentages because the patient groups, treatment protocols and outcomes measured were not identical.

The important takeaway: Always ask whether a quoted IUI success rate refers to pregnancy or live birth, and whether it is calculated per cycle or across multiple cycles.

Per-Cycle vs Cumulative IUI Success Rate: What Is the Difference?

Before comparing different IUI success rates, it is important to understand two commonly used measurements.

1. Per-Cycle Success Rate

The per-cycle success rate represents the probability of achieving a particular outcome from one IUI attempt.

For example, if a study reports a 10% pregnancy rate per cycle, it means approximately 10 out of every 100 comparable treatment cycles resulted in pregnancy.

It does not mean that every individual has exactly a 10% chance.

2. Cumulative Success Rate

The cumulative success rate measures the combined outcome across multiple treatment attempts.

For example, a study may report how many couples achieved an ongoing pregnancy after three, six or nine IUI cycles.

However, cumulative calculations depend on how researchers account for couples who discontinue treatment.

A Dutch multicentre study involving 3,714 couples demonstrated this difference clearly.

The same study reported a crude cumulative figure of 25% after nine cycles when treatment discontinuations were handled differently.

This is why two studies can report different cumulative percentages even when examining similar treatment outcomes.

Every IUI success-rate figure should ideally include three details:

1. Is it per cycle or cumulative?

2. Does it measure pregnancy or live birth?

3. Which patient group was included?

Published IUI Success Rates: What Does the Research Show?

Let's look at some of the major studies and published figures.

These figures should not be compared as if they measure the same outcome.

For example, the 15.7% figure from the American study represents clinical pregnancy in a selected group of stimulated-IUI cycles. The European registry's 8.8% represents deliveries per cycle across a much broader reporting population.

The difference is not necessarily a contradiction. The studies measured different outcomes in different patient populations.

No verified Indian national registry figure was available in the research reviewed for this article.

IUI Success Rate by Age: Does Age Matter?

Yes. A woman's age is one of the important factors considered during fertility treatment planning.

As age increases, changes in egg quantity and quality can influence the likelihood of conception and pregnancy.

A 2024 Chinese cohort study examined cumulative live-birth outcomes following IUI using partner sperm across different age groups.

Published cumulative live-birth figures by age

These figures come from one centre in China between 2017 and 2021. They represent crude cumulative live births across attempted cycles, not a standard per-cycle success rate.

They should therefore be interpreted as findings from a particular study rather than guaranteed outcomes for an individual.

What Does This Mean for Women Above 35?

Women in their late thirties may need a more carefully planned fertility strategy.

Age alone does not determine whether IUI is appropriate. However, it can influence how many treatment attempts are reasonable before reassessing the plan.

For women aged 40 and above, spending several months on a treatment with a relatively low predicted chance may not always be the most suitable approach.

A fertility specialist should consider age alongside ovarian reserve, medical history, sperm parameters and other investigations.

You can learn more about how age affects fertility and the chances of conception.

What Factors Influence IUI Success Rates?

IUI outcomes depend on several clinical factors. Understanding them can help couples have a more informed discussion with their fertility specialist.

1. Female Age

Age is an important consideration because reproductive potential changes over time.

The 2024 Chinese cohort showed lower cumulative live-birth rates in older age groups.

However, individual outcomes may differ, and age should always be considered alongside other fertility findings.

2. Reason for Infertility

The underlying reason a couple is experiencing difficulty conceiving can influence the treatment approach.

IUI may be considered in selected cases involving:

• Unexplained infertility.

• Certain ovulation disorders.

• Mild male-factor infertility.

• Selected situations requiring donor sperm.

For couples with unexplained infertility, treatment guidelines and research support considering ovarian stimulation with IUI in appropriate circumstances.

3. Natural-Cycle vs Stimulated IUI

IUI may be performed in a natural cycle or with medication to stimulate follicular development.

In a natural-cycle IUI, the procedure is timed around the woman's natural ovulation.

In stimulated IUI, medications such as clomiphene, letrozole or gonadotrophins may be used under medical supervision.

A Cochrane review found that stimulated IUI may improve cumulative live-birth outcomes compared with natural-cycle IUI in unexplained infertility.

However, the evidence was based on four relatively small trials and was graded as low certainty.

Ovarian stimulation also requires monitoring because multiple follicles may increase the possibility of multiple pregnancies.

In the European partner-sperm IUI registry data, 7.9% of deliveries were twins and 0.4% were triplets. These figures included both natural and stimulated cycles and do not establish the additional risk caused by stimulation.

4. Sperm Count After Washing

Sperm quality is another important consideration during IUI treatment.

Before insemination, the semen sample is processed to separate motile sperm from other components.

The number of motile sperm remaining after washing is an important parameter considered when assessing IUI suitability.

A systematic review of 55 studies found that the reported post-wash motile sperm thresholds varied between approximately 0.8 million and 5 million.

There is no universally agreed threshold or standard method across all studies.

This is why couples should ask their fertility specialist and laboratory how the post-wash sperm count is interpreted and whether it is suitable for IUI.

A low sperm count does not automatically rule out IUI, but significantly low post-wash motile counts may lead to a discussion about other treatment options, including IVF with ICSI.

5. Fallopian Tube Patency

At least one fallopian tube needs to be open for conventional IUI to have a chance of working.

If both fallopian tubes are blocked, IUI cannot achieve its intended purpose because the sperm and egg cannot meet through the normal tubal pathway.

If only one tube is open, the situation requires individual assessment before starting treatment.

Doctors may recommend investigations such as hysterosalpingography (HSG) or a foam ultrasound to assess whether the fallopian tubes are open.

Read more about checking fallopian tubes for blockages.

How Many IUI Cycles Should You Try Before IVF?

This is one of the most important decisions during fertility treatment.

Many couples hear that IUI stops working after three attempts. However, research does not support the idea that the per-cycle chance suddenly collapses after the third cycle.

The Dutch cohort reported an average ongoing pregnancy rate of 5.6% per cycle. The rates during cycles seven, eight and nine were 5.1%, 6.7% and 4.6%, respectively.

An American cohort published in 2024 also found that the predicted clinical pregnancy rate was 16.7% in the first cycle and 15.0% across cycles two to four.

The more important consideration is not whether IUI completely stops working after three attempts.

It is whether continuing treatment provides enough additional benefit compared with moving to another option.

What Do the Guidelines Recommend?

Different professional guidelines provide slightly different recommendations.

American Society for Reproductive Medicine (ASRM)

For unexplained infertility, ASRM generally recommends three or four cycles of ovarian stimulation using oral medications combined with IUI, followed by IVF if pregnancy has not occurred.

NICE 2026

The updated NICE guideline states that, after two years of trying to conceive, couples with unexplained infertility may consider up to four cycles of gonadotrophin-stimulated IUI before IVF, or IVF directly.

ESHRE 2023

The ESHRE guideline recommends stimulated IUI as a first-line treatment for unexplained infertility and states that IVF is probably not recommended over stimulated IUI, although the evidence supporting these recommendations is of very low certainty.

The recommendations differ in detail, so treatment decisions should be based on individual circumstances rather than applying one fixed number to everyone.

When Should You Consider Moving From IUI to IVF?

Continuing IUI indefinitely is not always the most suitable approach.

A change in treatment strategy may be discussed in situations such as:

• Three or four stimulated IUI cycles have not resulted in pregnancy.

• The woman is 40 years or older and the expected benefit from repeated IUI attempts is limited.

• Both fallopian tubes are blocked.

• The post-wash motile sperm count is below the laboratory's accepted threshold.

• The underlying fertility diagnosis suggests that IVF may be a more appropriate option.

• The couple prefers a potentially shorter treatment pathway and IVF is a suitable and affordable option.

In the FASTT trial, reported pregnancy rates per cycle were 7.6% for clomiphene-IUI, 9.8% for FSH-IUI and 30.7% for IVF.

These figures should not be treated as a direct randomised comparison of individual treatment-cycle success. The study evaluated different treatment pathways.

The decision to move to IVF should consider age, diagnosis, previous treatment, financial circumstances and personal preferences.

If IVF is not possible or is not preferred, the number of further IUI attempts should be discussed with the treating specialist.

IUI vs IVF: Which Treatment Is More Suitable?

IUI and IVF are different fertility treatments, and neither is automatically the right choice for every couple.

IUI may be considered as an initial treatment in selected couples with unexplained infertility or mild fertility-related concerns.

IVF may be considered when IUI is unlikely to be effective, when other fertility factors are present, or when the couple wants to consider a different treatment pathway.

In certain male-factor fertility situations, ICSI may also be considered as part of IVF treatment.

The most appropriate choice depends on the complete fertility evaluation.

For a more detailed comparison, read our guide on IUI, IVF or ICSI: Which treatment do you actually need?.

What Should You Ask Your Fertility Specialist About IUI Success Rates?

Before beginning treatment, make sure you understand what the quoted success rate actually represents.

Here is one useful question to ask during your consultation:

"Is that figure per cycle or cumulative, pregnancy or live birth, and for which patients?"

You can also discuss:

1. Is IUI suitable for my age and fertility diagnosis?

2. Are at least one of my fallopian tubes open?

3. What does my partner's post-wash motile sperm count indicate?

4. Should I consider natural-cycle or stimulated IUI?

5. How many treatment cycles should we plan before reviewing the strategy?

6. Under what circumstances would you recommend moving to IVF?

These questions can help you understand the reasoning behind the proposed treatment plan.

Frequently Asked Questions About IUI Success Rates

1. What is the IUI success rate on the first attempt?

In a 2024 American cohort involving stimulated-IUI cycles, the adjusted predicted clinical pregnancy rate was 16.7% during the first cycle. This figure represents clinical pregnancy in a selected patient group, not a universal live-birth rate.

2. How many IUI cycles should I try before IVF?

For unexplained infertility, ASRM generally suggests three or four oral-stimulation IUI cycles before moving to IVF. NICE 2026 allows consideration of up to four gonadotrophin-IUI cycles or IVF directly in the relevant clinical circumstances.

3. What is the IUI success rate at 35, 38 or 40?

A 2024 Chinese cohort reported cumulative live-birth rates using partner sperm of 27.6% under 35, 23.0% at 35–37, 13.7% at 38–39 and 6.9% at 40 and above. These are study-specific cumulative figures, not standard per-cycle rates.

4. Does a low sperm count rule out IUI?

Not necessarily. The post-wash motile sperm count is an important factor. A review of 55 studies reported thresholds ranging from 0.8 million to 5 million, with no universally accepted cut-off. Your doctor should interpret the result in the context of your overall fertility evaluation.

5. Is IUI with injections better than natural-cycle IUI?

Ovarian-stimulation IUI may improve cumulative live-birth outcomes compared with natural-cycle IUI in unexplained infertility. However, the supporting evidence is of low certainty, and stimulation requires monitoring because of the potential risk of multiple pregnancy.

6. IUI vs IVF: Which has a higher success rate?

In the FASTT trial, pregnancy rates per cycle were reported as 7.6% with clomiphene-IUI, 9.8% with FSH-IUI and 30.7% with IVF. These results came from a study of different treatment pathways and should not be interpreted as a direct head-to-head comparison of individual cycles.

Final Thoughts: Understanding Your IUI Treatment Journey

IUI can be an appropriate fertility treatment for selected couples, but its success depends on several factors.

Age, the reason for infertility, sperm quality after washing, fallopian tube patency and the type of treatment protocol all contribute to the overall assessment.

The research also shows why it is important to distinguish between per-cycle pregnancy rates, cumulative pregnancy rates and actual live births.

Three or four unsuccessful IUI attempts do not mean that treatment has suddenly stopped working. Instead, they provide an important opportunity to reassess whether continuing IUI or considering IVF is the more appropriate next step.

At Renew Healthcare, fertility decisions should be based on individual medical evaluation, published evidence and the circumstances of each couple.

About the Author

Dr. Neha Yadav
Associate Consultant
Renew Healthcare, Kolkata

Dr. Neha Yadav has over 11 years of experience in obstetrics, gynaecology and infertility care. She has worked with several hospitals, including Motherhood Hospitals, Bangalore, and Bhagirathi Neotia Hospitals, Newtown. Her clinical interests include infertility counselling and high-risk pregnancy care.

Read Dr. Neha Yadav's professional profile at Renew Healthcare.

Medical information in this article is intended for educational purposes and does not replace an individual consultation with a qualified medical professional. Treatment suitability and outcomes vary between individuals.

AI disclosure: This article was drafted with AI assistance and must be reviewed, edited and approved for publication by the named doctor before publishing, in accordance with the applicable medical communication guidelines.

References

1. European IVF-Monitoring Consortium (EIM) for ESHRE. ART in Europe, 2020: Results generated from European registries by ESHRE. Human Reproduction. 2025;40(11):2038–2055. https://doi.org/10.1093/humrep/deaf179

2. Custers IM, Steures P, Hompes P, et al. Intrauterine insemination: How many cycles should we perform? Human Reproduction. 2008;23(4):885–888. https://doi.org/10.1093/humrep/den008

3. Reindollar RH, Regan MM, Neumann PJ, et al. A randomized clinical trial to evaluate optimal treatment for unexplained infertility: The FASTT trial. Fertility and Sterility. 2010;94(3):888–899. https://doi.org/10.1016/j.fertnstert.2009.04.022

4. Evans MB, Hosseinzadeh P, Flannagan K, et al. Assessment of clinical pregnancies in up to eight ovarian stimulation with intrauterine insemination treatment cycles in those unable to proceed with in vitro fertilization. Fertility and Sterility. 2024;122(1):114–120. https://doi.org/10.1016/j.fertnstert.2024.02.018

5. Zhang D, Cai H, Xie J, Chen L, Zhang Z, Shi J. Cumulative live birth rates following intrauterine insemination using donor and husband sperm in different age groups. International Journal of Gynaecology and Obstetrics. 2024;167(1):142–153. https://doi.org/10.1002/ijgo.15539

6. Fan J, Li L, Xu H, Shu J, Zhang K. Comparative analysis of natural versus ovarian stimulation cycles in intrauterine insemination by diverse infertility indications. Annals of Medicine. 2026;58(1):2688370. https://doi.org/10.1080/07853890.2026.2688370

7. Ayeleke RO, Asseler JD, Cohlen BJ, Veltman-Verhulst SM. Intra-uterine insemination for unexplained subfertility. Cochrane Database of Systematic Reviews. 2020;(3). https://doi.org/10.1002/14651858.CD001838.pub6

8. Ombelet W, Dhont N, Thijssen A, Bosmans E, Kruger T. Semen quality and prediction of IUI success in male subfertility: A systematic review. Reproductive BioMedicine Online. 2014;28(3):300–309. https://doi.org/10.1016/j.rbmo.2013.10.023

9. National Institute for Health and Care Excellence. Fertility problems: Assessment and treatment. NICE Guideline NG257. 31 March 2026. https://www.nice.org.uk/guidance/ng257

10. ESHRE Guideline Group on Unexplained Infertility. Evidence-based guideline: Unexplained infertility. Human Reproduction. 2023;38(10):1881–1890. https://doi.org/10.1093/humrep/dead150

11. Practice Committee of the American Society for Reproductive Medicine. Evidence-based treatments for couples with unexplained infertility: A guideline. Fertility and Sterility. 2020;113(2):305–322. https://doi.org/10.1016/j.fertnstert.2019.10.014